Ms. Cheryl A. Laux, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1320 S St, Bridgeport, NE 69336 Phone: 308-262-1755 Fax: 308-262-0765 |
Amber E Malcolm, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1313 S St, Bridgeport, NE 69336 Phone: 308-262-1616 Fax: 308-262-0843 |
Kimberly R Perkins, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1313 S St, Bridgeport, NE 69336 Phone: 308-262-1616 |
Traci Lynnette Ellis, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1313 S St Ste A, Bridgeport, NE 69336 Phone: 308-262-1755 Fax: 308-262-0765 |
Melody J Leisy, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1313 S St, Bridgeport, NE 69336 Phone: 308-262-1616 |
News Archive
Scientists at KU Leuven, Belgium, have succeeded in growing three-dimensional cultures of the endometrium, the uterus' inner lining, in a dish.
Exercise can protect both muscle and nerves from damage caused by the restoration of blood flow after injury or surgery, new research from the University of Virginia School of Medicine shows.
It's dinnertime, and the smell of delicious food makes your tummy rumble. However, it's dark because of a powercut and you can't see very clearly. Should you try to 'follow your nose' to locate food? Or should you simply guess and peek into the kitchen, or the dining room or the veranda - the likeliest places for dinner to be served? A recent study shows that the latter method - dubbed 'run-and-scan' - may actually be more efficient in finding your target than just following your nose.
Scientists have sequenced the entire genomes of tumors from 50 breast cancer patients and found more than 1,700 gene mutations, most of which were unique to individual patients. The researchers at Washington University in St. Louis and the Siteman Cancer Center suggest that this variability and uniqueness made it difficult to predict outcomes of the cases.
The drug ingenol mebutate (trade name: Picato) has been approved in Germany since November 2012 as a gel for the treatment of certain forms of actinic keratosis in adults. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over diclofenac/hyaluronic acid gel. Such an added benefit cannot be derived from the dossier, however, as the drug manufacturer did not submit any relevant data: it did not cite any studies that directly compared ingenol mebutate with diclofenac/hyaluronic acid gel, and the method chosen by the manufacturer for an indirect comparison was unsuitable.
› Verified 5 days ago